Infectious Diseases and Therapy (Jun 2024)

Correction to: Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

  • Chris Wynne,
  • Abundio Balgos,
  • Jingxin Li,
  • Paul Hamilton,
  • Louie Tirador,
  • Anjuli May Jaen,
  • Chen Mo,
  • Zijing Yue,
  • Ying Ma,
  • Qingshuang Wang,
  • Rendu Wen,
  • Zheng Yao,
  • Jiaping Yu,
  • Wenrong Yao,
  • Jianhui Zhang,
  • Hui Zheng,
  • Kunxue Hong,
  • Fengcai Zhu,
  • Yong Liu

DOI
https://doi.org/10.1007/s40121-024-00998-z
Journal volume & issue
Vol. 13, no. 7
pp. 1723 – 1724

Abstract

Read online

No abstracts available.